Molecular Modeling as a New Approach to the Development of Urokinase Inhibitors.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2015, v. 158, n. 5, p. 700, doi. 10.1007/s10517-015-2839-3
- By:
- Publication type:
- Article
Works matching DE "UROKINASE genetics"
Results: 7
1
2
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells.
- Published in:
- Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-162
- By:
- Publication type:
- Article
3
Overexpression of forkhead box M1 and urokinase‑type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis.
- Published in:
- Oncology Letters, 2017, v. 14, n. 6, p. 7288, doi. 10.3892/ol.2017.7136
- By:
- Publication type:
- Article
4
Urokinase‐plasminogen activator protects periodontal ligament fibroblast from oxidative induced‐apoptosis and DNA damage.
- Published in:
- Journal of Periodontal Research, 2018, v. 53, n. 5, p. 861, doi. 10.1111/jre.12576
- By:
- Publication type:
- Article
5
Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD).
- Published in:
- Respiratory Research, 2013, v. 14, n. 11, p. 1, doi. 10.1186/1465-9921-14-120
- By:
- Publication type:
- Article
6
Association between the polymorphisms of urokinase plasminogen activation system and cancer risk: a meta-analysis.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 2493, doi. 10.2147/OTT.S85520
- By:
- Publication type:
- Article
7
Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells.
- Published in:
- eLife, 2017, p. 1, doi. 10.7554/eLife.23649.001
- By:
- Publication type:
- Article